This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa
The drug LEVEMIR contains one active pharmaceutical ingredient (API):
1
Insulin detemir
UNII 4FT78T86XV - INSULIN DETEMIR
|
Insulin detemir is a soluble, long-acting insulin analogue with a prolonged duration of effect used as a basal insulin. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
LEVEMIR Solution for injection | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
A10AE05 | Insulin detemir | A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10A Insulins and analogues → A10AE Insulins and analogues for injection, long-acting |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 12236B, 9040T |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 526602101153419, 526602102151411, 526602103156210 |
Country: CA | Health Products and Food Branch | Identifier(s): 02271842, 02412829 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 28527-08-08 |
Country: EE | Ravimiamet | Identifier(s): 1208001, 1208012, 1208023, 1208034, 1208045, 1208056, 1208067, 1208078, 1208089, 1639144, 1639155, 1639166 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 04278005, 04278008 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 019718, 019758, 094310 |
Country: FR | Base de données publique des médicaments | Identifier(s): 64529525, 66481292, 66688750 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 111482, 75895, 75900 |
Country: HK | Department of Health Drug Office | Identifier(s): 53538, 65011 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 63003, 63005, 63015, 63082, 63109 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 4811, 6587 |
Country: IT | Agenzia del Farmaco | Identifier(s): 036850016, 036850028, 036850030, 036850042, 036850055, 036850067, 036850079, 036850081, 036850093 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2492417A1038, 2492417G1030, 2492417G2029 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004369, 1029390, 1029391, 1029392, 1029393, 1029394, 1029395, 1029396, 1029397, 1054649, 1054650, 1064133, 1064134, 1064135, 1064136, 1064137 |
Country: NL | Z-Index G-Standaard | Identifier(s): 14719509, 14941260 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 75140, 75159 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 11102, 11104 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100127134 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W41731001, W41731002, W41731003, W41732001, W41732002, W41732003, W52352001, W52352002, W52352003 |
Country: SG | Health Sciences Authority | Identifier(s): 13115P, 15515P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5993071 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699676950782, 8699676950799 |
Country: US | FDA, National Drug Code | Identifier(s): 0169-3687, 0169-6438, 50090-1276, 50090-4501 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 38/21.1/0084 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.